Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174
-
Shares outstanding
-
55,833,616
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
217,709
-
Shares change
-
-1,753,749
-
Total reported value, excl. options
-
$282,000
-
Value change
-
-$1,721,326
-
Number of buys
-
3
-
Number of sells
-
-12
-
Price
-
$1.67
Significant Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) as of Q3 2022
15 filings reported holding CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 as of Q3 2022.
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 217,709 shares
of 55,833,616 outstanding shares and own 0.39% of the company stock.
Largest 10 shareholders include CITIGROUP INC (214,713 shares), ROCKY MOUNTAIN ADVISERS, LLC (1,200 shares), SIMPLEX TRADING, LLC (903 shares), UBS Group AG (496 shares), China Universal Asset Management Co., Ltd. (397 shares), JANUS HENDERSON GROUP PLC (0 shares), CITADEL ADVISORS LLC (0 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), Vident Investment Advisory, LLC (0 shares), and TWO SIGMA INVESTMENTS, LP (0 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.